Packer RJ, Goldwein J, Nicholson HS, Vezina LG, Allen JC, Ris MD, Muraszko K, Rorke LB, Wara WM, Cohen BH, et al: Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A Children’s Cancer Group Study. J Clin Oncol. 1999, 17 (7): 2127-2136.
CAS
PubMed
Google Scholar
Taylor RE, Bailey CC, Robinson K, Weston CL, Ellison D, Ironside J, Lucraft H, Gilbertson R, Tait DM, Walker DA, et al: Results of a randomized study of preradiation chemotherapy versus radiotherapy alone for nonmetastatic medulloblastoma: The International Society of Paediatric Oncology/United Kingdom Children’s Cancer Study Group PNET-3 Study. J Clin Oncol. 2003, 21 (8): 1581-1591. 10.1200/JCO.2003.05.116.
Article
CAS
PubMed
Google Scholar
Brown HG, Kepner JL, Perlman EJ, Friedman HS, Strother DR, Duffner PK, Kun LE, Goldthwaite PT, Burger PC: “Large cell/anaplastic” medulloblastomas: a Pediatric Oncology Group Study. J Neuropathol Exp Neurol. 2000, 59 (10): 857-865.
Article
CAS
PubMed
Google Scholar
Giangaspero F, Rigobello L, Badiali M, Loda M, Andreini L, Basso G, Zorzi F, Montaldi A: Large-cell medulloblastomas. A distinct variant with highly aggressive behavior. Am J Surg Pathol. 1992, 16 (7): 687-693. 10.1097/00000478-199207000-00007.
Article
CAS
PubMed
Google Scholar
Zeltzer PM, Boyett JM, Finlay JL, Albright AL, Rorke LB, Milstein JM, Allen JC, Stevens KR, Stanley P, Li H, et al: Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children’s Cancer Group 921 randomized phase III study. J Clin Oncol. 1999, 17 (3): 832-845.
CAS
PubMed
Google Scholar
Jenkin D, Shabanah MA, Shail EA, Gray A, Hassounah M, Khafaga Y, Kofide A, Mustafa M, Schultz H: Prognostic factors for medulloblastoma. Int J Radiat Oncol Biol Phys. 2000, 47 (3): 573-584. 10.1016/S0360-3016(00)00431-4.
Article
CAS
PubMed
Google Scholar
Yao MS, Mehta MP, Boyett JM, Li H, Donahue B, Rorke LB, Zeltzer PM: The effect of M-stage on patterns of failure in posterior fossa primitive neuroectodermal tumors treated on CCG-921: a phase III study in a high-risk patient population. Int J Radiat Oncol Biol Phys. 1997, 38 (3): 469-476. 10.1016/S0360-3016(97)00010-2.
Article
CAS
PubMed
Google Scholar
Phi JH, Lee J, Wang KC, Cho BK, Kim IO, Park CK, Kim CY, Ahn HS, Kim IH, Kim SK: Cerebrospinal fluid M staging for medulloblastoma: reappraisal of Chang’s M staging based on the CSF flow. Neuro Oncol. 2011, 13 (3): 334-344. 10.1093/neuonc/noq171.
Article
PubMed
Google Scholar
Burger PC, Heinz ER, Shibata T, Kleihues P: Topographic anatomy and CT correlations in the untreated glioblastoma multiforme. J Neurosurg. 1988, 68 (5): 698-704. 10.3171/jns.1988.68.5.0698.
Article
CAS
PubMed
Google Scholar
Chang CH, Housepian EM, Herbert C: An operative staging system and a megavoltage radiotherapeutic technic for cerebellar medulloblastomas. Radiology. 1969, 93 (6): 1351-1359.
Article
CAS
PubMed
Google Scholar
Gibson P, Tong Y, Robinson G, Thompson MC, Currle DS, Eden C, Kranenburg TA, Hogg T, Poppleton H, Martin J, et al: Subtypes of medulloblastoma have distinct developmental origins. Nature. 2010, 468 (7327): 1095-1099. 10.1038/nature09587.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kool M, Korshunov A, Remke M, Jones DT, Schlanstein M, Northcott PA, Cho YJ, Koster J, Schouten-van Meeteren A, van Vuurden D, et al: Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas. Acta Neuropathol. 2012, 123 (4): 473-484. 10.1007/s00401-012-0958-8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Northcott PA, Korshunov A, Witt H, Hielscher T, Eberhart CG, Mack S, Bouffet E, Clifford SC, Hawkins CE, French P, et al: Medulloblastoma comprises four distinct molecular variants. J Clin Oncol. 2011, 29 (11): 1408-1414. 10.1200/JCO.2009.27.4324.
Article
PubMed
Google Scholar
Parsons DW, Li M, Zhang X, Jones S, Leary RJ, Lin JC, Boca SM, Carter H, Samayoa J, Bettegowda C, et al: The genetic landscape of the childhood cancer medulloblastoma. Science. 2011, 331 (6016): 435-439. 10.1126/science.1198056.
Article
CAS
PubMed
Google Scholar
Wu X, Northcott PA, Dubuc A, Dupuy AJ, Shih DJ, Witt H, Croul S, Bouffet E, Fults DW, Eberhart CG, et al: Clonal selection drives genetic divergence of metastatic medulloblastoma. Nature. 2012, 482 (7386): 529-533. 10.1038/nature10825.
Article
CAS
PubMed
PubMed Central
Google Scholar
Mumert M, Dubuc A, Wu X, Northcott PA, Chin SS, Pedone CA, Taylor MD, Fults DW: Functional genomics identifies drivers of medulloblastoma dissemination. Cancer Res. 2012, 72 (19): 4944-4953. 10.1158/0008-5472.CAN-12-1629.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhou L, Picard D, Ra YS, Li M, Northcott PA, Hu Y, Stearns D, Hawkins C, Taylor MD, Rutka J, et al: Silencing of thrombospondin-1 is critical for myc-induced metastatic phenotypes in medulloblastoma. Cancer Res. 2010, 70 (20): 8199-8210. 10.1158/0008-5472.CAN-09-4562.
Article
CAS
PubMed
Google Scholar
Bai AH, Milde T, Remke M, Rolli CG, Hielscher T, Cho YJ, Kool M, Northcott PA, Jugold M, Bazhin AV, et al: MicroRNA-182 promotes leptomeningeal spread of non-sonic hedgehog-medulloblastoma. Acta Neuropathol. 2012, 123 (4): 529-538. 10.1007/s00401-011-0924-x.
Article
CAS
PubMed
Google Scholar
Perk J, Iavarone A, Benezra R: Id family of helix-loop-helix proteins in cancer. Nat Rev Cancer. 2005, 5 (8): 603-614. 10.1038/nrc1673.
Article
CAS
PubMed
Google Scholar
Sikder HA, Devlin MK, Dunlap S, Ryu B, Alani RM: Id proteins in cell growth and tumorigenesis. Cancer Cell. 2003, 3 (6): 525-530. 10.1016/S1535-6108(03)00141-7.
Article
CAS
PubMed
Google Scholar
Asirvatham AJ, Carey JP, Chaudhary J: ID1-, ID2-, and ID3-regulated gene expression in E2A positive or negative prostate cancer cells. Prostate. 2007, 67 (13): 1411-1420. 10.1002/pros.20633.
Article
CAS
PubMed
Google Scholar
Hu YC, Lam KY, Law S, Wong J, Srivastava G: Identification of differentially expressed genes in esophageal squamous cell carcinoma (ESCC) by cDNA expression array: overexpression of Fra-1, Neogenin, Id-1, and CDC25B genes in ESCC. Clin Cancer Res. 2001, 7 (8): 2213-2221.
CAS
PubMed
Google Scholar
Lin CQ, Singh J, Murata K, Itahana Y, Parrinello S, Liang SH, Gillett CE, Campisi J, Desprez PY: A role for Id-1 in the aggressive phenotype and steroid hormone response of human breast cancer cells. Cancer Res. 2000, 60 (5): 1332-1340.
CAS
PubMed
Google Scholar
Okaji Y, Tsuno NH, Kitayama J, Sakurai D, Tsuchiya N, Saito S, Takegami K, Tsuchiya T, Kawai K, Yazawa K, et al: Effects of down-regulating the Id genes in human colorectal cancer cells on early steps of haematogenous metastasis. Eur J Cancer. 2006, 42 (5): 668-673. 10.1016/j.ejca.2005.11.016.
Article
CAS
PubMed
Google Scholar
Shuno Y, Tsuno NH, Okaji Y, Tsuchiya T, Sakurai D, Nishikawa T, Yoshikawa N, Sasaki K, Hongo K, Tsurita G, et al: Id1/Id3 knockdown inhibits metastatic potential of pancreatic cancer. J Surg Res. 2010, 161 (1): 76-82. 10.1016/j.jss.2008.10.031.
Article
CAS
PubMed
Google Scholar
Gupta GP, Perk J, Acharyya S, de Candia P, Mittal V, Todorova-Manova K, Gerald WL, Brogi E, Benezra R, Massague J: ID genes mediate tumor reinitiation during breast cancer lung metastasis. Proc Natl Acad Sci U S A. 2007, 104 (49): 19506-19511. 10.1073/pnas.0709185104.
Article
CAS
PubMed
PubMed Central
Google Scholar
Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods. 2001, 25 (4): 402-408. 10.1006/meth.2001.1262.
Article
CAS
PubMed
Google Scholar
Phi JH, Park SH, Kim SK, Paek SH, Kim JH, Lee YJ, Cho BK, Park CK, Lee DH, Wang KC: Sox2 expression in brain tumors: a reflection of the neuroglial differentiation pathway. Am J Surg Pathol. 2008, 32 (1): 103-112. 10.1097/PAS.0b013e31812f6ba6.
Article
PubMed
Google Scholar
Shimato S, Natsume A, Takeuchi H, Wakabayashi T, Fujii M, Ito M, Ito S, Park IH, Bang JH, Kim SU, et al: Human neural stem cells target and deliver therapeutic gene to experimental leptomeningeal medulloblastoma. Gene Ther. 2007, 14 (15): 1132-1142. 10.1038/sj.gt.3302932.
Article
CAS
PubMed
Google Scholar
Northcott PA, Shih DJ, Peacock J, Garzia L, Morrissy AS, Zichner T, Stutz AM, Korshunov A, Reimand J, Schumacher SE, et al: Subgroup-specific structural variation across 1,000 medulloblastoma genomes. Nature. 2012, 488 (7409): 49-56. 10.1038/nature11327.
Article
CAS
PubMed
PubMed Central
Google Scholar
Yan W, Young AZ, Soares VC, Kelley R, Benezra R, Zhuang Y: High incidence of T-cell tumors in E2A-null mice and E2A/Id1 double-knockout mice. Mol Cell Biol. 1997, 17 (12): 7317-7327.
Article
CAS
PubMed
PubMed Central
Google Scholar
Loveys DA, Streiff MB, Kato GJ: E2A basic-helix-loop-helix transcription factors are negatively regulated by serum growth factors and by the Id3 protein. Nucleic Acids Res. 1996, 24 (14): 2813-2820. 10.1093/nar/24.14.2813.
Article
CAS
PubMed
PubMed Central
Google Scholar
Fong S, Debs RJ, Desprez PY: Id genes and proteins as promising targets in cancer therapy. Trends Mol Med. 2004, 10 (8): 387-392. 10.1016/j.molmed.2004.06.008.
Article
CAS
PubMed
Google Scholar
Anido J, Saez-Borderias A, Gonzalez-Junca A, Rodon L, Folch G, Carmona MA, Prieto-Sanchez RM, Barba I, Martinez-Saez E, Prudkin L, et al: TGF-beta receptor inhibitors target the CD44(high)/Id1(high) glioma-initiating cell population in human glioblastoma. Cancer Cell. 2010, 18 (6): 655-668. 10.1016/j.ccr.2010.10.023.
Article
CAS
PubMed
Google Scholar
Li B, Tsao SW, Li YY, Wang X, Ling MT, Wong YC, He QY, Cheung AL: Id-1 promotes tumorigenicity and metastasis of human esophageal cancer cells through activation of PI3K/AKT signaling pathway. Int J Cancer. 2009, 125 (11): 2576-2585. 10.1002/ijc.24675.
Article
CAS
PubMed
Google Scholar
Cheung PY, Yip YL, Tsao SW, Ching YP, Cheung AL: Id-1 induces cell invasiveness in immortalized epithelial cells by regulating cadherin switching and Rho GTPases. J Cell Biochem. 2011, 112 (1): 157-168. 10.1002/jcb.22911.
Article
CAS
PubMed
Google Scholar
Coma S, Amin DN, Shimizu A, Lasorella A, Iavarone A, Klagsbrun M: Id2 promotes tumor cell migration and invasion through transcriptional repression of semaphorin 3F. Cancer Res. 2010, 70 (9): 3823-3832. 10.1158/0008-5472.CAN-09-3048.
Article
CAS
PubMed
PubMed Central
Google Scholar
Puget S, Grill J, Valent A, Bieche I, Dantas-Barbosa C, Kauffmann A, Dessen P, Lacroix L, Geoerger B, Job B, et al: Candidate genes on chromosome 9q33-34 involved in the progression of childhood ependymomas. J Clin Oncol. 2009, 27 (11): 1884-1892. 10.1200/JCO.2007.15.4195.
Article
CAS
PubMed
Google Scholar
Fiorilli P, Partridge D, Staniszewska I, Wang JY, Grabacka M, So K, Marcinkiewicz C, Reiss K, Khalili K, Croul SE: Integrins mediate adhesion of medulloblastoma cells to tenascin and activate pathways associated with survival and proliferation. Lab Invest. 2008, 88 (11): 1143-1156. 10.1038/labinvest.2008.89.
Article
CAS
PubMed
PubMed Central
Google Scholar
Vo DT, Subramaniam D, Remke M, Burton TL, Uren PJ, Gelfond JA, de Sousa AR, Burns SC, Qiao M, Suresh U, et al: The RNA-binding protein Musashi1 affects medulloblastoma growth via a network of cancer-related genes and is an indicator of poor prognosis. Am J Pathol. 2012, 181 (5): 1762-1772. 10.1016/j.ajpath.2012.07.031.
Article
CAS
PubMed
PubMed Central
Google Scholar